Skip to main navigation Skip to search Skip to main content

Serum tetranectin is a significant prognostic marker in ovarian cancer patients

7 Citations (Scopus)

Abstract

To evaluate the prognostic value of preoperative serum tetranectin (TN) in Danish ovarian cancer (OvCa) patients. Design. Population-based, multidisciplinary Danish case-control study of OvCa.
Original languageEnglish
JournalActa Obstetricia et Gynecologica Scandinavica
Volume89
Issue number2
Pages (from-to)190-8
Number of pages9
ISSN0001-6349
DOIs
Publication statusPublished - 1 Jan 2010

Fingerprint

Dive into the research topics of 'Serum tetranectin is a significant prognostic marker in ovarian cancer patients'. Together they form a unique fingerprint.

Cite this